Neuro Event Labs is a Tampere company that makes Nelli, a seizure detection and analysis service for epilepsy care.
Founded in 2015 and headquartered in Tampere, Finland, Neuro Event Labs Oy makes Nelli, a service that uses machine learning to detect and analyze motor seizures. Nelli is CE-marked as a class I medical device in the EU and is investigational in the US, where it holds FDA Breakthrough Device designation. The company raised EUR 3.9 million in Series A funding on April 8, 2020, from Hadean Ventures, Maki.vc and SHS Gesellschaft für Beteiligungsmanagement. In 2023 it reported revenue of EUR 898,324.2 and EBITDA of EUR -2,740,862.3.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in